Profit Or Loss [Abstract]

Marinomed Biotech AG - Filing #1079021

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
11,628 EUR
8,124 EUR
Other income
1,575 EUR
1,161 EUR
Raw materials and consumables used
6,428 EUR
5,414 EUR
Employee benefits expense
4,462 EUR
4,098 EUR
Depreciation and amortisation expense
6,089,000 EUR
4,284,000 EUR
Other expenses, by nature
2,073 EUR
1,809 EUR
Profit (loss) from operating activities
4,145 EUR
5,816 EUR
Finance income
0 EUR
5,230,000 EUR
Finance costs
1,550 EUR
7,137,000 EUR
Profit (loss) before tax
5,694 EUR
6,007 EUR
Tax expense (income)
1,971,000 EUR
35,000 EUR
Profit (loss)
- EUR
- EUR
5,891 EUR
5,891 EUR
6,010 EUR
- EUR
6,010 EUR
- EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
40,000
41,000
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
40,000
41,000

Talk to a Data Expert

Have a question? We'll get back to you promptly.